The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Wed., Jun. 29, 10:05 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #19. Bristol-Myers Squibb iPierian, Inc.

Acquirer: Bristol-Myers Squibb (NYSE:BMY)
Acquiree: iPierian, Inc.
Details: Bristol-Myers Squibb Company (NYSE:BMY) and iPierian, Inc. announced today that Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological aggregation of Tau protein in the human brain.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

Bristol-Myers Squibb SEC Filing Email Alerts Service


Open the BMY Page at The Online Investor »

Company Name: 
Bristol Myers Squibb Co.
Website: 
www.bms.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding BMY: 
126
Total Market Value Held by ETFs: 
$22.32B
Total Market Capitalization: 
$168.11B
% of Market Cap. Held by ETFs: 
13.28%
 

Open the BMY Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree BMY Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.85 out of 4)
9th percentile
(ranked lower than approx. 91% of all stocks covered)

Analysts' Target Price:
BMY Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 19 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.